Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting synthetic lethal paralogs in cancer
Colm J. Ryan, Ishan Mehta, Narod Kebabci, et al.
Trends in cancer (2023) Vol. 9, Iss. 5, pp. 397-409
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives
Viola Previtali, Greta Bagnolini, Andrea Ciamarone, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11488-11521
Open Access | Times Cited: 20
Complex synthetic lethality in cancer
Colm J. Ryan, Lovely Paul Solomon Devakumar, Stephen J. Pettitt, et al.
Nature Genetics (2023) Vol. 55, Iss. 12, pp. 2039-2048
Closed Access | Times Cited: 23
Cryo-shocked tumor cells deliver CRISPR-Cas9 for lung cancer regression by synthetic lethality
F Liu, Minhang Xin, Huiheng Feng, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 15
CROPseq-multi: a versatile solution for multiplexed perturbation and decoding in pooled CRISPR screens
Russell T. Walton, Yue Qin, Paul C. Blainey
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
Intratumor Heterogeneity and Treatment Resistance of Solid Tumors with a Focus on Polyploid/Senescent Giant Cancer Cells (PGCCs)
Razmik Mirzayans, David Murray
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11534-11534
Open Access | Times Cited: 20
MYC in liver cancer: mechanisms and targeted therapy opportunities
Furong Liu, Zhibin Liao, Zhanguo Zhang
Oncogene (2023) Vol. 42, Iss. 45, pp. 3303-3318
Closed Access | Times Cited: 17
Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm
Nesrine Lajmi, Sofia Alves-Vasconcelos, Apostolos Tsiachristas, et al.
Cambridge Prisms Precision Medicine (2024) Vol. 2
Open Access | Times Cited: 8
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
Jean C. Tien, Jie Luo, Yu Chang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 10, pp. 101758-101758
Open Access | Times Cited: 6
Expanding the ligandable proteome by paralog hopping with covalent probes
Yuanjin Zhang, Zhonglin Liu, Marsha Hirschi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Chufan Cai, Jiayi Tu, Jeronimo Najarro, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 4, pp. 386-401
Open Access | Times Cited: 5
State of the art CRISPR-based strategies for cancer diagnostics and treatment
Emma Di Carlo, Carlo Sorrentino
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Mitoferrin2 is a synthetic lethal target for chromosome 8p deleted cancers
Stephan Krieg, Thomas D. Rohde, Tobias Rausch, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Paralog dispensability shapes homozygous deletion patterns in tumor genomes
Barbara De Kegel, Colm J. Ryan
Molecular Systems Biology (2023) Vol. 19, Iss. 12
Open Access | Times Cited: 10
Computational modeling of human genetic variants in mice
Kexin Dong, Samuel I. Gould, Minghang Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Identifying KDM5B as the synthetic lethal target of KMT2D-mutated osteosarcoma
Liyu Yang, Jing Zhang, Yiting Jiang, et al.
Chemico-Biological Interactions (2025) Vol. 412, pp. 111451-111451
Closed Access
BaCoN (Balanced Correlation Network) improves prediction of gene buffering
Thomas D. Rohde, Talip Yasir Demirtas, Sebastian Süsser, et al.
Molecular Systems Biology (2025)
Open Access
Incomplete paralog compensation generates selective dependency on TRA2A in cancer
A. Lee, Anna Tangiyan, Isha Singh, et al.
PLoS Genetics (2025) Vol. 21, Iss. 5, pp. e1011685-e1011685
Open Access
Frequent loss of FAM126A expression in colorectal cancer results in selective FAM126B dependency
Shuang Li, Ting Han
iScience (2024) Vol. 27, Iss. 5, pp. 109646-109646
Open Access | Times Cited: 3
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors
Tancredi Didier Bazan Russo, Clarissa Mujacic, Emilia Di Giovanni, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 11, pp. 1619-1631
Open Access | Times Cited: 3
CDK12 Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic Lethality
Jean C. Tien, Yu Chang, Yuping Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
VRK1 Regulates Sensitivity to Oxidative Stress by Altering Histone Epigenetic Modifications and the Nuclear Phosphoproteome in Tumor Cells
Elena Navarro-Carrasco, Eva Monte-Serrano, Aurora Campos-Díaz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4874-4874
Open Access | Times Cited: 1
Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells
Mingyue Liu, Zhangxiang Zhao, Chengyu Wang, et al.
Cancer Letters (2024) Vol. 594, pp. 216991-216991
Closed Access | Times Cited: 1
Methylation synthetic lethality: Exploiting selective drug targets for cancer therapy
B. Hilda Ye, Di‐Fei Li, Xinyun Li, et al.
Cancer Letters (2024) Vol. 597, pp. 217010-217010
Closed Access | Times Cited: 1
Targeting the Sodium-Potassium Pump as a Therapeutic Strategy in Acute Myeloid Leukemia
Constanze Schneider, Hermes Spaink, Gabriela Alexe, et al.
Cancer Research (2024) Vol. 84, Iss. 20, pp. 3354-3370
Closed Access | Times Cited: 1
An allosteric cyclin E-CDK2 site mapped by paralog hopping with covalent probes
Yuanjin Zhang, Zhonglin Liu, Marscha Hirschi, et al.
Nature Chemical Biology (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top